LTB ‐ TREAT : A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma
British Journal of Haematology · 2026-10 · 209 (4) · 1673-1683
DOI: 10.1111/bjh.70748 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Haematology, online erschienen am 27.08.2026. Verfasst von Luani Barge und 25 weiteren Autor:innen. Beteiligte Einrichtung: Princess Alexandra Hospital, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Lymphoma, Follicular, Time-to-Treatment, Watchful Waiting. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Watchful waiting (WW) in low tumour burden follicular lymphoma (LTB FL) defers treatment. There is a need to develop a model to predict time to treatment (TTT). We aimed to develop and externally validate a model for TTT in LTB FL. We conducted a retrospective analysis across eight centres within the Australasian Lymphoma Alliance. Two hundred and twenty‐nine patients were included between 2004 and 2022 with a median follow‐up of 5.0 years (range 0.5–17.8 years) and a median age was 64 years. All patients were Group d'Etude des Lymphomes Folliculaires (GELF) negative and managed with WW. Elevated lactate dehydrogenase and >4 nodal areas were independent prognostic factors associated with shorter TTT. These factors formed a prognostic model identifying three groups: low 59% (median TTT 6.34 years), intermediate 36% (median TTT 4.08 years), high risk 5% (median TTT 1.49 years) ( p < 0.001). There was a higher incidence of serious complications among risk groups (low 7.5% vs. intermediate 13.3% vs. high 25%; p = 0.096). The prognostic value of the LTB‐TREAT model was confirmed in an external validation cohort. The low‐risk group is predicted to have a prolonged TTT with WW and a high‐risk group is predicted to experience early progression in whom treatment should be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Princess Alexandra Hospital, Brisbane, Queensland, Australia.
- School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
- Olivia Newton John Cancer Research Institute at Austin Hospital, Melbourne, Victoria, Australia.
- Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
- Westmead Hospital, Sydney, New South Wales, Australia.
ORCID-Profile: Lachlan Webb, Niamh Waters, Ross Salvaris, Nada Hamad, Sylvain Choquet, Lukshe Kanagaratnam, Chan Y Cheah, Eliza A Hawkes, Kirk Morris, Eric Durot, Greg Hapgood
Zitieren
APA
Barge, L., Webb, L., Pelecanos, A., Waters, N., Salvaris, R., Lai, S., Potezny, T., Cashman, H., Nguyen-Ngo, C., Lee, D., Yannakou, C. K., Hamad, N., Chauchet, A., Choquet, S., Rossi, C., Herbin, A., Kanagaratnam, L., Rodier, C., Tam, C. S., …, & Hapgood, G. (2026). LTB ‐ TREAT : A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma. British Journal of Haematology, 209(4), 1673-1683. https://doi.org/10.1111/bjh.70748
Vancouver
Barge L, Webb L, Pelecanos A, Waters N, Salvaris R, Lai S, et al. LTB ‐ TREAT : A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma. British Journal of Haematology. 2026;209(4):1673-1683. doi:10.1111/bjh.70748
BibTeX
@article{Barge2026,
author = {Barge, Luani and Webb, Lachlan and Pelecanos, Anita and Waters, Niamh and Salvaris, Ross and Lai, Sam and Potezny, Tessa and Cashman, Helen and Nguyen-Ngo, Caitlyn and Lee, Denise and Yannakou, Costas K and Hamad, Nada and Chauchet, Adrien and Choquet, Sylvain and Rossi, Cédric and Herbin, Adélie and Kanagaratnam, Lukshe and Rodier, Cyrielle and Tam, Constantine S and Bhattacharyya, Abir and Cheah, Chan Y and Hawkes, Eliza A and Morris, Kirk and Durot, Eric and Tobin, Joshua and Hapgood, Greg},
title = {LTB ‐ TREAT : A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma},
journal = {British Journal of Haematology},
year = {2026},
volume = {209},
number = {4},
pages = {1673--1683},
doi = {10.1111/bjh.70748}
}
EUVIMED